NUFORMIX
SHARE PRICE
0.37
CHANGE
-0.025 ( -6.33%)
TICKER
NFX.L
Share Chart
Latest Articles for NFX.L
IN BRIEF: Nuformix submits FDA drug designation application for NXP002
Nuformix PLC - London-based developer of treatments for fibrosis and oncology - Submits US Food & Drug Administration orphan drug designation application for the NXP002 programme in idiopathic pulmonary fibrosis....
Nuformix shares fall despite EU orphan drug status for lead treatment
(Alliance News) - Nuformix PLC on Thursday said its lead programme, NXP002, has been granted orphan drug designation by the European Medicines Agency for the treatment of idiopathic pulmonary fibrosis....
Nuformix interim loss widens as focused on advancing assets
(Alliance News) - Nuformix PLC on Friday said it has continued to "advance and exploit" assets in its portfolio, two days after noting a positive opinion from an EU committee...
Nuformix finds positive data for NXP002 in lung fibrosis study
(Alliance News) - Nuformix PLC on Wednesday said fresh analysis of lung tissue from patients with idiopathic pulmonary fibrosis and autoimmune-related interstitial lung disease showed "positive" results for its lead...